uBriGene offers GMP manufacturing platforms for RNA-based therapies. Our GMP compliant microfluidic LNP system ensures batch consistency, control, and high yields.
uBriGene offers GMP RNA production solutions for RNA-based therapies including GMP mRNA manufacturing, saRNA production, and circRNA production services. Our GMP compliant microfluidic LNP system delivers consistent batch-to-batch performance, precise process control, high yields, and large scale mRNA production for clinical and commercial applications.
High-efficiency GMP mRNA-LNP manufacturing platform with advanced RNA and LNP analytical technologies for consistent quality and performance.
uBriGene's GMP circRNA production services deliver >90% pure circRNA therapeutics with high expression, potency, and safety for RNA-based therapies.
Innovative saRNA production platform delivering high-quality self-amplifying RNA (saRNA) therapeutics with >80% integrity.
Unveil uBriGene’s RNA and LNP manufacturing capacities and testing.
Redefining RNA Therapeutics: GMP RNA-LNP Manufacturing You Can Trust
Unveil the current manufacturing approaches for LVV and its deployment in cell therapies.
Learn about CAR-T production process & regulatory guidelines.
